1,105 filings
Page 2 of 56
4
Andrew Obenshain
9 Jan 24
bluebird bio / Andrew Obenshain ownership change
4:05pm
4
Richard A Colvin
9 Jan 24
bluebird bio / Richard A Colvin ownership change
4:05pm
SC 13G/A
BLK
Blackrock Inc.
8 Jan 24
bluebird bio / BlackRock ownership change
4:35pm
8-K
BLUE
Bluebird bio Inc
8 Jan 24
Anticipate 85 to 105 patient starts (cell collections) across commercial portfolio in 2024 with first patient start for LYFGENIA expected in Q1 2024
8:03am
8-K
BLUE
Bluebird bio Inc
4 Jan 24
Regulation FD Disclosure
8:00am
424B5
BLUE
Bluebird bio Inc
20 Dec 23
Prospectus supplement for primary offering
5:05pm
8-K
BLUE
Bluebird bio Inc
20 Dec 23
Entry into a Material Definitive Agreement
7:42am
424B5
BLUE
Bluebird bio Inc
18 Dec 23
Prospectus supplement for primary offering
5:07pm
8-K
BLUE
Bluebird bio Inc
18 Dec 23
Entry into a Material Definitive Agreement
4:48pm
8-K
BLUE
Bluebird bio Inc
14 Dec 23
Regulation FD Disclosure
7:30am
8-K
BLUE
Bluebird bio Inc
11 Dec 23
Regulation FD Disclosure
8:06am
4
Christopher Krawtschuk
8 Dec 23
bluebird bio / Christopher Krawtschuk ownership change
4:42pm
10-Q
2023 Q3
BLUE
Bluebird bio Inc
Quarterly report
7 Nov 23
7:03am
8-K
BLUE
Bluebird bio Inc
7 Nov 23
Results of Operations and Financial Condition
7:01am
4
Andrew Obenshain
3 Nov 23
bluebird bio / Andrew Obenshain ownership change
4:10pm
4
Richard A Colvin
3 Nov 23
bluebird bio / Richard A Colvin ownership change
4:10pm
8-K
BLUE
Bluebird bio Inc
30 Oct 23
Entry into a Material Definitive Agreement
8:05am
8-K
BLUE
Bluebird bio Inc
27 Sep 23
Entry into a Material Definitive Agreement
7:00am
4
Thomas J Klima
6 Sep 23
bluebird bio / Thomas J Klima ownership change
4:30pm
4
Andrew Obenshain
10 Aug 23
bluebird bio / Andrew Obenshain ownership change
5:00pm